Literature DB >> 10988044

Paracetamol as a prophylactic analgesic for hysterosalpingography: a double blind randomized controlled trial.

E M Elson1, N T Ridley.   

Abstract

AIM: To evaluate the effectiveness of paracetamol as a prophylactic analgesic for hysterosalpingography (HSG).
DESIGN: A prospective double blind randomized controlled trial comparing one 1 g of paracetamol (SmithKline Beecham, Brentford, U.K.) to placebo taken 30 min before HSG. One hundred consecutive out-patients were studied prospectively. The analgesic effectiveness during the procedure and at 24 h and 1 week post procedure was analysed by a postal pain score questionnaire. Additional data on the ethnicity of the patient, sex and level of experience of the radiologist performing the hysterosalpingogram, the parity of the patient, the ease of the procedure, and whether pathology was identified were also recorded.
RESULTS: Eighty-eight patients (88%) replied, 39 (44%) received paracetamol and 49 placebo (56%). During the procedure 3/39 (7%) of women in the paracetamol group were pain-free compared to 9/49 (18%) in the placebo group, which was not significant (P = 0.11). At 24 h, 15/39 (38%) of women in the paracetamol group were pain-free compared to 20/49 (41%) in the placebo group, which was not significant (P = 0.82). At 1 week, 27/39 (69%) of women in the paracetamol group were pain-free compared to 29/49 (59%) in the placebo group, which was not significant (P = 0.33). No significant difference in mean pain scores was determined during the procedure (P = 0.91), or at 24 h post procedure (P = 0.94). Similarly, no difference in mean pain scores was identified with regard to the ethnicity of the patient, the sex of the radiologist performing the procedure, the level of experience of the radiologist performing the procedure, or whether pathology was present or not. Difficult cannulations were associated with higher mean pain scores, however, there was no difference in mean pain scores between the paracetamol or placebo groups for both easy and difficult cannulations.
CONCLUSION: Paracetamol is not effective as a prophylactic analgesic for HSG. If a prophylactic analgesic is considered necessary for pain relief during HSG we recommend that a non-steroidal anti-inflammatory drug (NSAID) is used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988044     DOI: 10.1053/crad.2000.0563

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram.

Authors:  E A Bachman; S Senapati; M D Sammel; S K Kalra
Journal:  Reprod Biomed Online       Date:  2014-03-04       Impact factor: 3.828

2.  Comparison of four different pain relief methods during hysterosalpingography: a randomized controlled study.

Authors:  Bekir Serdar Unlu; Mehmet Yilmazer; Gulengul Koken; Dagistan Tolga Arioz; Ebru Unlu; Elif Dogan Baki; Cemile Kurttay; Osman Karacin
Journal:  Pain Res Manag       Date:  2015 Mar-Apr       Impact factor: 3.037

3.  Comparison of midazolam and dexmedetomidine for pain relief during and after hysterosalpingography in women with infertility.

Authors:  Fatemeh Safi; Leila Rabiee; Maryam Shokrpour; Alireza Kamali
Journal:  J Med Life       Date:  2019 Apr-Jun

Review 4.  Effectiveness of interventions for pain relief in hysterosalpingographyAnetwork meta-analysis and systematic review.

Authors:  Xin Guo; Zongjian Tan
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

5.  Immersive virtual reality as analgesia for women during hysterosalpingography: study protocol for a randomized controlled trial.

Authors:  Yi-Ling Wang; Hai-Xiang Gao; Jin-She Wang; Jing-Hui Wang; Lei Bo; Ting-Ting Zhang; Ya-Liang Dai; Lu-Lu Gao; Qiang Liu; Jun-Jun Zhang; Ju-Min Cai; Jian-Qiang Yu; Yu-Xiang Li
Journal:  Trials       Date:  2020-01-20       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.